Whitehawk Therapeutics (WHWK) Divestments (2025 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Divestments of -$70000.0 for Q3 2025, down 100.07% quarter-over-quarter from $101.4 million in Q1 2025.
Whitehawk Therapeutics (WHWK) Divestments (2025 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Divestments for 1 consecutive years, with -$70000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Divestments changed N/A year-over-year to -$70000.0; the TTM figure through Mar 2026 stood at -$70000.0 (down 100.07% YoY), while the FY2025 annual figure was $101.3 million, changed N/A from the prior year.
- Divestments retreated to -$70000.0 in Q3 2025 per WHWK's latest filing, from $101.4 million in the prior quarter.
- Across five years, Divestments topped out at $101.4 million in Q1 2025 and bottomed at -$70000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | -102.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -102.40 Mn |
| Mar 31, 2026 | 102.40 Mn |
| Sep 30, 2025 | -70,000.00 |
| Mar 31, 2025 | 101.36 Mn |